Average Rx Sales In Independent Pharmacies Stagnate Under Part D, NCPA-Pfizer Data Indicate
This article was originally published in The Pink Sheet Daily
Executive Summary
Preliminary data from financial/demographic study support previous anecdotal reports of financial difficulty for independent pharmacies due to Part D reimbursement practices.